Back to Search Start Over

Metabolomics analysis in adults with High Bone Mass identifies a relationship between bone resorption and circulating citrate which replicates in the general population

Authors :
Celia L Gregson
Debbie A Lawlor
Jon H Tobias
Lavinia Paternoster
April Hartley
William D. Fraser
David M. Evans
Jonathan Tang
Source :
Hartley, A, Paternoster, L, Evans, D, Fraser, W D, Tang, J, Lawlor, D A, Tobias, J H & Gregson, C L 2019, ' Metabolomics analysis in adults with High Bone Mass identifies a relationship between bone resorption and circulating citrate which replicates in the general population ', Clinical Endocrinology . https://doi.org/10.1111/cen.14119, Clinical Endocrinology
Publication Year :
2019

Abstract

Objective Bone turnover, which regulates bone mass, may exert metabolic consequences, particularly on markers of glucose metabolism and adiposity. To better understand these relationships, we examined cross-sectional associations between bone turnover markers (BTMs) and metabolic traits in a population with high bone mass (HBM, BMD Z-score >=+3.2). Design beta-C-terminal telopeptide of type-I collagen (beta-CTX), procollagen type-1 amino-terminal propeptide (P1NP) and osteocalcin were assessed by electrochemiluminescence immunoassays. Metabolic traits, including lipids and glycolysis-related metabolites, were measured using nuclear magnetic resonance spectroscopy. Associations of BTMs with metabolic traits were assessed using generalized estimating equation linear regression, accounting for within-family correlation, adjusting for potential confounders (age, sex, height, weight, menopause, bisphosphonate and oral glucocorticoid use). Results A total of 198 adults with HBM had complete data, mean [SD] age 61.6 [13.7] years; 77% were female. Of 23 summary metabolic traits, citrate was positively related to all BTMs: adjusted beta(beta-CTX) = 0.050 (95% CI 0.024, 0.076), P = 1.71 x 10(-4), beta(osteocalcin) = 6.54 x 10(-4) (1.87 x 10(-4), 0.001), P = .006 and beta(P1NP) = 2.40 x 10(-4) (6.49 x 10(-5), 4.14 x 10(-4)), P = .007 (beta = increase in citrate (mmol/L) per 1 mu g/L BTM increase). Inverse relationships of beta-CTX (beta = -0.276 [-0.434, -0.118], P = 6.03 x 10(-4)) and osteocalcin (-0.004 [-0.007, -0.001], P = .020) with triglycerides were also identified. We explored the generalizability of these associations in 3664 perimenopausal women (age 47.9 [4.4] years) from a UK family cohort. We confirmed a positive, albeit lower magnitude, association between beta-CTX and citrate (adjusted beta(women) = 0.020 [0.013, 0.026], P = 1.95 x 10(-9)) and an inverse association of similar magnitude between beta-CTX and triglycerides (beta = -0.354 [-0.471, -0.237], P = 3.03 x 10(-9)). Conclusions Bone resorption is positively related to circulating citrate and inversely related to triglycerides. Further studies are justified to determine whether plasma citrate or triglyceride concentrations are altered by factors known to modulate bone resorption, such as bisphosphonates.

Details

Language :
English
Database :
OpenAIRE
Journal :
Hartley, A, Paternoster, L, Evans, D, Fraser, W D, Tang, J, Lawlor, D A, Tobias, J H & Gregson, C L 2019, ' Metabolomics analysis in adults with High Bone Mass identifies a relationship between bone resorption and circulating citrate which replicates in the general population ', Clinical Endocrinology . https://doi.org/10.1111/cen.14119, Clinical Endocrinology
Accession number :
edsair.doi.dedup.....be28a28c615e7d4758d78df19595157c